Bondrova 3mg/3ml

IV Infusion
Ibandronic Acid
Healthcare Pharmaceuticals

Other Strength:
- Bondrova 150mg

Alternative:



Bondrova
Description
Osteoporosis causes the body to remove more bone than it replaces. This means that bones get weaker. Weak bones are more likely to break. Osteoporosis is a bone disease that is quite common in women after menopause. It also affects men. At first, osteoporosis has no symptoms, but people with osteoporosis may develop loss of height and are more likely to break (fracture) their bones, especially the back (spine), wrist, and hip bones. Osteoporosis can be prevented, and with proper therapy it can be treated.

Ibandronic acid inhibits osteoclast activity and reduces bone resorption and turnover. In postmenopausal women, it reduces the elevated rate of bone turnover, leading to a progressive gain in bone mass. The absorption of ibandronate occurs in the upper gastrointestinal tract. After absorption, ibandronate either rapidly binds to bone or is excreted unchanged into urine.

Indications
Bondrova is indicated for the:
Treatment of osteoporosis in women (specially postmenopausal)
Prevention of osteoporosis in women (specially postmenopausal)
Prevention and treatment of osteoporosis in men

Supply
Bondrova 150 mg tablet: Each box contains 1 tablet in Alu-Alu blister.
Bondrova 3mg/3ml injection: Each box containing one prefilled syringe of 3mg/3ml solution for injection

এই পাতাটি ২৫২ বার দেখা হয়েছে